Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Benzimidazole analogs inhibit respiratory syncytial virus G protein function.

Antiviral research - 1 Sept 2015

Evans Carrie W, Atkins Colm, Pathak Ashish, Gilbert Brian E, Noah James W

Abstract excerpt

Human respiratory syncytial virus (hRSV) is a highly contagious Paramyxovirus that infects most children by age two, generating an estimated 75,000-125,000 hospitalizations in the U.S. annually. hRSV is the most common cause of bronchiolitis and pneumonia among infants and children under 1year of age, with significant mortality among high-risk groups. A regulatory agency-approved vaccine is not available, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzimidazoles
Share to High-Throughput Screening Assays
Share to Mutant Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Respiratory Syncytial Virus, Human

Share to Respiratory Syncytial Virus Infections

Share to Sigmodontinae

Share to Viral Envelope Proteins

Share to Virus Attachment

Source

Open in PubMed Open full text

Identifiers

PMID: 26116756
DOI: 10.1016/j.antiviral.2015.06.016
PMCID: PMC7185459

Genes

SRI

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Benzimidazole analogs inhibit respiratory syncytial virus G protein function.PMID 26116756Read ↗

Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitorSemantic proximity Read ↗

Structure-guided design of small-molecule therapeutics against RSV diseaseSemantic proximity Read ↗

Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.Semantic proximity Read ↗

Orally active fusion inhibitor of respiratory syncytial virus.Semantic proximity Read ↗

Ginkgolic acid inhibits orthopneumo- and metapneumo- virus infectivitySemantic proximity Read ↗

Drug candidates and model systems in respiratory syncytial virus antiviral drug discovery.Semantic proximity Read ↗

Antiviral activity and molecular mechanism of an orally active respiratory syncytial virus fusion inhibitorSemantic proximity Read ↗

New triazole triterpene derivative exhibits anti-RSV activity synthesis biological evaluation and molecular modelingSemantic proximity Read ↗

Respiratory syncytial virus fusion inhibitors. Part 5: Optimization of benzimidazole substitution patterns towards derivatives with improved activity.Semantic proximity Read ↗

Orally efficacious lead of the AVG inhibitor series targeting a dynamic interface in the respiratory syncytial virus polymeraseSemantic proximity Read ↗

Discovery of a Novel Respiratory Syncytial Virus Replication InhibitorSemantic proximity Read ↗

RSV604, a novel inhibitor of respiratory syncytial virus replication.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.